Does intermittent fasting increase HGH? Research suggests it can — fasting triggers measurable, transient rises in growth hormone (GH) secretion through well-understood physiological mechanisms, including falling insulin levels and rising ghrelin. These changes reflect a natural adaptive hormonal response rather than a therapeutic effect. However, fasting simultaneously reduces IGF-1 and induces hepatic GH resistance, limiting any anabolic benefit. This article explains what the current evidence shows, the mechanisms involved, who may be affected differently, and when to seek medical advice before starting a fasting regimen.

How Intermittent Fasting Affects Growth Hormone Levels

Intermittent fasting produces measurable, transient increases in GH secretion as an adaptive response to falling insulin levels, but these changes are short-lived and do not replicate pharmacological GH therapy.

Intermittent fasting (IF) refers to structured eating patterns that cycle between defined periods of fasting and eating. Common protocols include the 16:8 method (16 hours fasting, 8 hours eating), the 5:2 diet, and alternate-day fasting. IF is one dietary approach that some people use for weight management; however, current evidence suggests it produces broadly similar outcomes to continuous energy restriction rather than being clearly superior.^[6][7] Beyond weight management, IF has attracted growing interest for its potential influence on hormonal regulation — particularly growth hormone (GH), also known as somatotropin or, in older literature, human growth hormone (HGH).

GH is a peptide hormone produced and secreted by the anterior pituitary gland.^[13][15] It plays a central role in growth, cellular repair, metabolism, and body composition. GH is released in pulses throughout the day, with the largest surges occurring during deep sleep and in response to physiological stressors such as exercise and fasting.

Research suggests that fasting can lead to measurable, transient increases in GH secretion. These elevations are thought to reflect a natural adaptive response to reduced caloric intake and falling insulin levels. It is important to understand, however, that these changes are short-lived and context-dependent — they do not replicate the pharmacological GH levels achieved through medical treatment, and their long-term clinical significance remains under investigation.

What the Current Evidence Says About Fasting and Growth Hormone

Evidence confirms a genuine but transient fasting-induced rise in GH; however, studies are often small and short-term, and no specific hormonal advantage over standard calorie restriction has been robustly established.

The scientific literature on fasting and GH is growing, though much of it derives from small-scale or short-duration studies, and direct comparisons between protocols are difficult.

A landmark study by Ho et al. (1988), published in the Journal of Clinical Investigation, demonstrated that fasting substantially increased 24-hour GH secretion in healthy adults. Subsequent work by Hartman and colleagues in the early 1990s further characterised fasting-induced changes in GH pulse frequency and amplitude. Some studies involving prolonged fasts (24–48 hours) have reported increases in GH secretion of up to five-fold in certain individuals; however, this figure derives from older, small studies using extended water-only fasting and should not be generalised to typical time-restricted eating patterns such as the 16:8 protocol.^[1][10]

It is important to contextualise these findings carefully:

• Study populations are often small and may not reflect the general UK population.

• Duration and type of fasting varies considerably between studies — acute multi-day fasts differ substantially from everyday time-restricted eating.

• Long-term clinical outcomes — such as meaningful changes in muscle mass, bone density, or longevity — have not been robustly demonstrated from fasting-induced GH elevation alone.

• Recent high-quality randomised controlled trials, including a 2020 RCT published in JAMA Internal Medicine, found that time-restricted eating produced modest weight and body composition changes broadly comparable to standard calorie restriction, with no specific hormonal advantage established.^[2][3]

Overall, while the evidence supports a genuine, physiologically meaningful but transient rise in GH during fasting, the clinical translation of this effect for healthy individuals requires further robust, longitudinal research before firm conclusions can be drawn.

Physiological Mechanisms Linking Fasting to Growth Hormone Secretion

Fasting raises GH primarily by lowering insulin and increasing ghrelin, but simultaneously reduces IGF-1 and induces hepatic GH resistance, limiting the net anabolic effect.

Understanding why fasting increases GH requires an appreciation of the hormonal interplay that governs its secretion. GH release is primarily regulated by two hypothalamic hormones: growth hormone-releasing hormone (GHRH), which stimulates secretion, and somatostatin, which inhibits it. Several metabolic signals modulate this balance.

Insulin suppression is one of the most significant mechanisms. When food — particularly carbohydrates — is consumed, insulin levels rise. Elevated insulin suppresses GH secretion. During fasting, insulin levels fall substantially, removing this inhibitory effect and allowing GH pulses to become more frequent and pronounced.

Ghrelin, often referred to as the 'hunger hormone', also plays a role. Ghrelin levels rise during fasting and act as a potent stimulator of GH release by binding to growth hormone secretagogue receptors in the pituitary gland.^[13][14] This creates a dual mechanism by which fasting promotes GH secretion.

Reduced insulin-like growth factor 1 (IGF-1) levels during fasting also contribute. IGF-1, produced primarily in the liver in response to GH, normally exerts negative feedback on GH secretion. During caloric restriction, IGF-1 levels decline, reducing this feedback inhibition and further amplifying GH output.

Crucially, however, fasting also induces a state of hepatic GH resistance — the liver becomes less responsive to GH signalling — and IGF-1 levels fall rather than rise.^[16][17] This means that despite higher circulating GH, the downstream anabolic effects (such as tissue growth and protein synthesis) are substantially attenuated during fasting. Fasting-induced GH rises therefore do not replicate the anabolic effects of pharmacological GH therapy.

These mechanisms collectively explain why fasting can produce a meaningful hormonal response, whilst also highlighting that the net physiological effect is more complex than a simple increase in GH activity.

Who May Be Affected Differently by Fasting-Induced Growth Hormone Changes

Older adults, people with obesity, and those with insulin resistance tend to have a blunted GH response to fasting; children, pregnant women, and those with eating disorders should avoid intermittent fasting.

The GH response to fasting is not uniform across all individuals. Several factors influence both baseline GH secretion and the degree to which fasting amplifies it.

Age is a significant variable. GH secretion naturally declines with age — an age-related process sometimes referred to as the somatopause (a descriptive term for this gradual decline, rather than a formal clinical diagnosis) — meaning that older adults may experience a more blunted GH response to fasting compared with younger individuals.^[20][21]

Sex also plays a role. Women generally have higher baseline GH pulse frequency than men, and oestrogen influences pituitary GH secretion. Some evidence suggests that women may respond differently to fasting-induced GH changes, though data are limited.

Body composition is another important consideration:

• Individuals with obesity tend to have lower baseline GH levels and a more blunted pulsatile response, partly due to higher circulating insulin and IGF-1 levels.

• Those with type 2 diabetes or insulin resistance may also show altered GH dynamics during fasting.

• Individuals with growth hormone deficiency should not use intermittent fasting as a substitute for medically supervised GH therapy.

Intermittent fasting is not generally recommended for the following groups, and medical advice should be sought before considering any fasting protocol:

• Children and young people under 18 years

• Underweight or frail adults (including those with a low BMI)

• Pregnant or breastfeeding women

• People with type 1 diabetes

• People with a current or recent history of an eating disorder

• Older adults who are frail or at risk of malnutrition

The British Dietetic Association (BDA) and NHS both advise that these groups should avoid IF or seek specialist guidance before proceeding.

Clinical Relevance and UK Guidance on Fasting Protocols

Neither NICE nor the NHS endorses intermittent fasting specifically to raise GH levels; any dietary approach should be individualised, and those on relevant medications must seek GP advice before fasting.

From a clinical perspective, the GH-elevating effects of intermittent fasting are of physiological interest, but they should be understood within the broader context of overall health rather than viewed as a primary therapeutic goal. Neither NICE nor the NHS endorses intermittent fasting specifically for the purpose of increasing GH levels.

NICE guidance on obesity management (CG189: Obesity: identification, assessment and management) and associated public health guidance (PH53: Weight management: lifestyle services for overweight or obese adults) support structured, multi-component approaches to weight management that include dietary modification. These guidelines do not recommend any specific dietary pattern, including IF, over others; rather, they emphasise that calorie-restricted approaches should be tailored to the individual. Time-restricted eating may be a suitable option for some people within a broader calorie-restricted programme, but it is not endorsed as a distinct or superior strategy.

The potential benefits associated with fasting-induced GH changes — such as modest improvements in body composition or fat metabolism — are biologically plausible but should not be overstated. As noted above, fasting simultaneously lowers IGF-1 and induces hepatic GH resistance, limiting any anabolic effect. These changes are best considered as one component of a holistic lifestyle approach that includes balanced nutrition, regular physical activity, and adequate sleep.

For individuals considering intermittent fasting, the following practical points are worth noting:

• Hydration should be maintained throughout fasting periods.

• Nutritional adequacy must be ensured during eating windows to avoid micronutrient deficiencies.

• Fasting protocols should be individualised based on health status, lifestyle, and personal preference.

• Those taking medications — particularly insulin, sulfonylureas, or SGLT2 inhibitors — should consult their GP or pharmacist before starting any fasting regimen, as dose adjustments may be required and there are specific safety risks (see below).

Fasting is not a licensed medicinal product or medical device, and it is not regulated by the MHRA in that capacity. Individuals should be cautious of commercial products or programmes making unsubstantiated claims about GH modulation through fasting.

When to Speak to a GP About Hormonal Changes and Fasting

Seek GP advice before fasting if you have a pituitary disorder, diabetes, or take insulin, sulfonylureas, or SGLT2 inhibitors, as fasting carries specific hormonal and metabolic safety risks in these groups.

Whilst intermittent fasting is generally considered safe for healthy adults, there are circumstances in which medical advice should be sought before or during a fasting regimen — particularly when hormonal health is a concern.

You should contact your GP if you experience any of the following whilst fasting:

• Persistent fatigue or weakness that does not resolve with rest

• Dizziness, fainting, or palpitations, which may indicate hypoglycaemia or electrolyte imbalance

• Significant unintentional weight loss beyond what is expected

• Menstrual irregularities, which may signal disruption to the hypothalamic-pituitary-gonadal axis

• Mood disturbances, including low mood, anxiety, or difficulty concentrating

If you have a pre-existing diagnosis of a pituitary disorder, adrenal insufficiency, thyroid disease, or diabetes, it is essential to discuss any planned dietary changes with your endocrinologist or GP before proceeding. People taking steroid replacement therapy for adrenal insufficiency should follow their sick day rules and seek endocrinology advice before undertaking any fasting protocol, rather than adjusting doses independently. People taking SGLT2 inhibitors (such as dapagliflozin, empagliflozin, or canagliflozin) should be aware that prolonged fasting or significant carbohydrate restriction can increase the risk of diabetic ketoacidosis (DKA), including euglycaemic DKA — a risk highlighted in MHRA and NHS safety communications.^[23][24] Clinician review is essential before fasting in this group. Similarly, those on insulin or sulfonylureas are at risk of hypoglycaemia and should not self-adjust their doses without medical guidance.

There is no established clinical role for fasting as a treatment or prevention strategy for growth hormone deficiency. Individuals who suspect they have a hormonal imbalance — including symptoms such as persistent fatigue, reduced muscle mass, increased adiposity, or poor recovery — should seek formal assessment through their GP. Where GH deficiency is suspected, the GP may refer to an endocrinologist for appropriate investigation, including serum IGF-1 measurement and, if indicated, dynamic stimulation testing, in line with Society for Endocrinology guidance and NICE TA64 (which covers somatropin for adults with confirmed GH deficiency).^[26]

In summary, intermittent fasting can modestly and transiently increase GH levels through well-understood physiological mechanisms. However, these rises occur alongside reduced IGF-1 and hepatic GH resistance, limiting their anabolic significance. Fasting should be approached as part of a holistic, evidence-informed lifestyle strategy rather than a standalone hormonal intervention, and medical advice should always be sought where there is any uncertainty about individual suitability.

Frequently Asked Questions